Drug
Loxapine clinical trials
Also written ADASUVE.
- studies test it
- 21
- open now
- 0
- in phase 3
- 4
- first study started
- 2003
How studies write it
Studies that test it under each name
Studies by the year they started
21 studies that test it; most in 2009 (5)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 5 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 8
- Phase 2
- 4
- Phase 3
- 4
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 16 · Other 5
Alexza Pharmaceuticals, Inc. (12) · Assistance Publique - Hôpitaux de Paris (2) · Nova Pneuma Inc. (1) · Mylan Pharmaceuticals Inc (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1) · University of Witten/Herdecke (1) · University of Arkansas (1) · University Hospital, Rouen (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Loxapine is read from its arms, and is right about nine times in ten.
Testing it · 21
- Staccato Loxapine Thorough QT/QTc StudyCompletedPhase 1Nova Pneuma Inc.NCT00874237Written as Inhaled loxapine
- Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mgCompletedPhase 1Mylan Pharmaceuticals IncNCT00648778Written as Loxapine Succinate Capsules 25 mg
- Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic PainTerminatedPhase 2University of Witten/HerdeckeNCT02820519Written as Loxapine
- Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic MedicationCompletedPhase 1Teva Branded Pharmaceutical Products R&D, Inc.NCT02184767Written as ADASUVE®
- A Study of Staccato Loxapine (ADASUVE®) for InhalationStatus unknownPhase 3Lee's Pharmaceutical LimitedNCT04148963Written as Inhaled loxapine
- Staccato Loxapine Pulmonary Safety in Healthy VolunteersCompletedPhase 1Alexza Pharmaceuticals, Inc.NCT00789360Written as Inhaled Loxapine
- Staccato Loxapine Single Dose PKCompletedPhase 1Alexza Pharmaceuticals, Inc.NCT00444028Written as inhaled Loxapine 0.625 mg
- Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for AgitationTerminatedPhase 4University of ArkansasNCT03110900Written as Loxapine
- Staccato Loxapine in Agitation (Proof of Concept)CompletedPhase 2Alexza Pharmaceuticals, Inc.NCT00369577Written as Inhaled Loxapine 5 mg
- ADASUVE-Lorazepam Drug-Drug InteractionCompletedPhase 4Alexza Pharmaceuticals, Inc.NCT01877642Written as Inhaled loxapine 10 mg
- ADASUVE 2-dose Thorough QT/QTc StudyCompletedPhase 4Alexza Pharmaceuticals, Inc.NCT01854710Written as ADASUVE 10 mg 2 doses 2 hours apart
- Staccato Loxapine in Agitated Patients With SchizophreniaCompletedPhase 3Alexza Pharmaceuticals, Inc.NCT00628589Written as Inhaled loxapine 5 mg
- Staccato Loxapine in Agitated Patients With Bipolar DisorderCompletedPhase 3Alexza Pharmaceuticals, Inc.NCT00721955Written as Inhaled loxapine 5 mg
- Staccato Loxapine in Migraine (in Clinic)CompletedPhase 2Alexza Pharmaceuticals, Inc.NCT00489476Written as Staccato Loxapine
- Staccato Loxapine in Migraine (Out Patient)CompletedPhase 2Alexza Pharmaceuticals, Inc.NCT00825500Written as Inhaled Loxapine 1.25 mg
- Staccato Loxapine PK in Smokers and NonsmokersCompletedPhase 1Alexza Pharmaceuticals, Inc.NCT00873769Written as Inhaled Loxapine 10 mg
- Staccato Loxapine Pulmonary Safety in Patients With AsthmaCompletedPhase 1Alexza Pharmaceuticals, Inc.NCT00890175Written as Inhaled loxapine @ 0 & 10 h
- Staccato Loxapine Pulmonary Safety in Patients With COPDCompletedPhase 1Alexza Pharmaceuticals, Inc.NCT00889837Written as Inhaled Loxapine
- Randomized Double-blind Trial of Midazolam and Loxapine in Agitated PatientsTerminatedPhase 3University Hospital, RouenNCT00290082Written as loxapine, midazolam
- Loxapine in the Management of Restlessness During Mechanical Ventilation WeaningCompletedPhase 4Assistance Publique - Hôpitaux de ParisNCT01193816Written as loxapine
See all 21 studies that test Loxapine →
As the comparator · 1 — what is tested is compared with Loxapine
Codes
What other systems call Loxapine · ClinicalTrials.gg INT007750
- MeSH (NLM) D008152LoxapineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) LER583670JLOXAPINEConfirmed FDA, NLM, Wikidata
- RxNorm 6475Confirmed FDA, Wikidata
- Wikidata Q58614loxapineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61816LoxapineOne source FDA
- DrugBank DB00408One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008152 | Loxapine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | LER583670J | LOXAPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6475 | — | Confirmed FDA, Wikidata |
| Wikidata | Q58614 | loxapine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61816 | Loxapine | One source FDA |
| DrugBank | DB00408 | — | One source Wikidata |
Also registered as loxapine hydrochloride (UNII 376MYL4MAL · RxNorm 91138) and loxapine succinate (UNII X59SG0MRYU · RxNorm 6476).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.